Synergistic inhibition of ovarian cancer cell growth by combining selective PI3K/mTOR and RAS/ERK pathway inhibitors
Citation
Sheppard, K, Cullinane, C, Hannan, K et al. 2013, 'Synergistic inhibition of ovarian cancer cell growth by combining selective PI3K/mTOR and RAS/ERK pathway inhibitors', European Journal of Cancer, vol. 49, no. 18, pp. 3936-3944.Year
2013ANU Authors
Fields of Research
- Receptors And Membrane Biology
- Cancer Cell Biology
- Molecular Targets